Akin Aynur, Guler Gulen, Esmaoglu Aliye, Bedirli Nurdan, Boyaci Adem
Department of Anesthesiology, Erciyes University School of Medicine, Kayseri 38039, Turkey.
J Clin Anesth. 2005 May;17(3):187-90. doi: 10.1016/j.jclinane.2004.06.019.
The purpose of this study was to compare the clinical activities of ketamine and fentanyl when used in combination with propofol for outpatients undergoing endometrial biopsy. The investigated parameters were respiration, sedation, recovery rate, side effects, time to discharge, and patient satisfaction.
Prospective, randomized, double-blind study.
University hospital.
Forty American Society of Anesthesiologists physical status I and II patients (age range 38-61 years) scheduled for elective endometrial biopsy.
Patients received intravenous bolus doses of either fentanyl 1 microg/kg and propofol 1 mg/kg in (group 1 n = 20) or ketamine 0.5 mg/kg and propofol 1 mg/kg in (group 2 n = 20).
Heart rate, systolic and diastolic blood pressure, respiratory rate, and peripheral O(2) saturation were monitored in all patients. Depth of sedation was assessed by the Ramsay sedation score. The Aldrete score was used for postoperative recovery evaluation. The time to Aldrete score >/=8, side effects, and time to discharge were recorded.
Respiratory depression was observed in 5 patients from group 1 and 1 patient from group 2, but the difference was not significant (P > .05). Nausea, vertigo, and visual disturbances were more frequent in group 2 (P < .05). The time to Aldrete score >/=8 was similar in the 2 groups (6.2 +/- 3.5 minutes in group 1 and 7.0 +/- 3.1 minutes in group 2); the time to discharge was significantly longer in group 2 (71.2 +/- 9.7 minutes in group 1 and 115.2 +/- 25.6 minutes in group 2). Frequency of patient satisfaction was 95% in group 1 and 60% in group 2.
Hemodynamic change and degrees of sedation showed that fentanyl-propofol and ketamine-fentanyl combinations can be used safely in patients undergoing endometrial biopsy. However, with regard to side effects and patient satisfaction, the fentanyl-propofol was superior.
本研究旨在比较氯胺酮和芬太尼与丙泊酚联合用于接受子宫内膜活检的门诊患者时的临床效果。研究参数包括呼吸、镇静、恢复率、副作用、出院时间和患者满意度。
前瞻性、随机、双盲研究。
大学医院。
40例美国麻醉医师协会身体状况为I级和II级的患者(年龄范围38 - 61岁),计划进行择期子宫内膜活检。
患者静脉推注芬太尼1微克/千克和丙泊酚1毫克/千克(第1组,n = 20)或氯胺酮0.5毫克/千克和丙泊酚1毫克/千克(第2组,n = 20)。
所有患者均监测心率、收缩压和舒张压、呼吸频率及外周血氧饱和度。通过Ramsay镇静评分评估镇静深度。采用Aldrete评分评估术后恢复情况。记录达到Aldrete评分≥8分的时间、副作用及出院时间。
第1组5例患者和第2组1例患者出现呼吸抑制,但差异无统计学意义(P > 0.05)。第2组恶心、眩晕和视觉障碍更为常见(P < 0.05)。两组达到Aldrete评分≥8分的时间相似(第1组为6.2 ± 3.5分钟,第2组为7.0 ± 3.1分钟);第2组出院时间明显更长(第1组为71.2 ± 9.7分钟,第2组为115.2 ± 25.6分钟)。第1组患者满意度为95%,第2组为60%。
血流动力学变化和镇静程度表明,芬太尼 - 丙泊酚及氯胺酮 - 芬太尼联合用药可安全用于接受子宫内膜活检的患者。然而,在副作用和患者满意度方面,芬太尼 - 丙泊酚更具优势。